Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive examination. Advocates often stress the possibility for meaningful therapeutic outcomes, especially in diseases where conventional therapies have proven limited. However, crucially important to assess the substantial financial burden associated with CPI stem cell